TCR CURE Biopharma Technology Co., Ltd.
Recent events
Recent events tied to this brand in public sources.
Back to profile1 entries
2022
Tianqiya completes funding round exceeding RMB 300 million
Tianqiya announced that it had completed a funding round of more than RMB 300 million. AstraZeneca CICC Healthcare Industry Fund and CCBI (Beijing) Investment Fund led the round, with existing investors also participating.